These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 10780267

  • 1. Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors.
    Ekins S, Bravi G, Binkley S, Gillespie JS, Ring BJ, Wikel JH, Wrighton SA.
    Pharmacogenetics; 1999 Aug; 9(4):477-89. PubMed ID: 10780267
    [Abstract] [Full Text] [Related]

  • 2. Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors.
    Ekins S, Bravi G, Binkley S, Gillespie JS, Ring BJ, Wikel JH, Wrighton SA.
    Drug Metab Dispos; 2000 Aug; 28(8):994-1002. PubMed ID: 10901712
    [Abstract] [Full Text] [Related]

  • 3. Three- and four-dimensional quantitative structure activity relationship analyses of cytochrome P-450 3A4 inhibitors.
    Ekins S, Bravi G, Binkley S, Gillespie JS, Ring BJ, Wikel JH, Wrighton SA.
    J Pharmacol Exp Ther; 1999 Jul; 290(1):429-38. PubMed ID: 10381809
    [Abstract] [Full Text] [Related]

  • 4. 4D-QSAR analysis of a series of antifungal p450 inhibitors and 3D-pharmacophore comparisons as a function of alignment.
    Liu J, Pan D, Tseng Y, Hopfinger AJ.
    J Chem Inf Comput Sci; 2003 Jul; 43(6):2170-9. PubMed ID: 14632469
    [Abstract] [Full Text] [Related]

  • 5. Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6.
    Ekins S, Bravi G, Ring BJ, Gillespie TA, Gillespie JS, Vandenbranden M, Wrighton SA, Wikel JH.
    J Pharmacol Exp Ther; 1999 Jan; 288(1):21-9. PubMed ID: 9862748
    [Abstract] [Full Text] [Related]

  • 6. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors.
    Roy PP, Roy K.
    Chem Biol Drug Des; 2009 Apr; 73(4):442-55. PubMed ID: 19291105
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance.
    Ekins S, Obach RS.
    J Pharmacol Exp Ther; 2000 Nov; 295(2):463-73. PubMed ID: 11046077
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T, Zhu L, Chen L, Xu X.
    J Chem Inf Comput Sci; 2003 Nov; 43(1):273-87. PubMed ID: 12546563
    [Abstract] [Full Text] [Related]

  • 14. Three-dimensional quantitative structure-activity relationship (3D-QSAR) analyses of choline acetyltransferase inhibitors.
    Chandrasekaran V, McGaughey GB, Cavallito CJ, Bowen JP.
    J Mol Graph Model; 2004 Sep; 23(1):69-76. PubMed ID: 15331055
    [Abstract] [Full Text] [Related]

  • 15. LQTA-QSAR: a new 4D-QSAR methodology.
    Martins JP, Barbosa EG, Pasqualoto KF, Ferreira MM.
    J Chem Inf Model; 2009 Jun; 49(6):1428-36. PubMed ID: 19422246
    [Abstract] [Full Text] [Related]

  • 16. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA, Gadad AK.
    J Med Chem; 2006 Jan 26; 49(2):475-89. PubMed ID: 16420035
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
    Guo Y, Xiao J, Guo Z, Chu F, Cheng Y, Wu S.
    Bioorg Med Chem; 2005 Sep 15; 13(18):5424-34. PubMed ID: 15963726
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.